ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 22348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 22348; 2) Community: the network communities that were significantly associated with the response to NSC 22348; 3) Molecule: the relationships between components within communities and NSC 22348; 4) MDR: the compounds that were significantly associated with the NSC 22348.

NSC Compound Enrichment Correlation
NSC 623436 TGF.alpha.-PE40 0.0462077035966084 -0.18900201
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0462077035966084 0.3224936
NSC 625878 Null 0.0462077035966084 0.53165051
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0462077035966084 0.41215683
NSC 639187 Landomycin A 0.0462077035966084 0.52025105
NSC 641594 Null 0.0462077035966084 0.33320643
NSC 645317 Sanguilutine pseudobase 0.0462077035966084 0.53293868
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.0462077035966084 0.45610259
NSC 654379 ANTINEOPLASTIC-654379 0.0462077035966084 0.49403625
NSC 656209 Null 0.0462077035966084 0.33914368
Total:143  Current:135    [First] [Prev] [Next] [Last]